SOURCE: Eurand N.V.

Eurand N.V.

March 04, 2009 09:00 ET

Eurand to Present at Cowen Health Care Conference

PHILADELPHIA, PA--(Marketwire - March 4, 2009) - Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Cowen Health Care Conference. John Fraher, Eurand's Chief Commercial Officer, will be presenting.

Event:    Cowen Health Care Conference
Date:     Wednesday, March 18, 2009
Time:     11:00 a.m. ET
Location: Boston Marriott Copley Place Hotel, Boston, Mass.

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at www.eurand.com. A replay of the presentation will be available until April 18, 2009.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.

Contact Information